复星医药建议委任刘毅为执行董事

Group 1 - The company Fosun Pharma (600196)(02196) announced the resignation of Mr. Wu Yifang as a non-executive director, effective from September 30, 2025 [1] - The company proposed the appointment of Mr. Liu Yi as an executive director of the tenth board of directors [1]